Oligonucleotide ligation assay for detecting mutations in the human immunodeficiency virus type 1 pol gene that are associated with resistance to zidovudine, didanosine, and lamivudine.
about
Prevalence and impact of minority variant drug resistance mutations in primary HIV-1 infectionLongitudinal Detection and Persistence of Minority Drug-Resistant Populations and Their Effect on Salvage TherapySimplified Paper Format for Detecting HIV Drug Resistance in Clinical Specimens by Oligonucleotide LigationIntrapartum tenofovir and emtricitabine reduces low-concentration drug resistance selected by single-dose nevirapine for perinatal HIV prevention.Validation of an oligonucleotide ligation assay for quantification of human immunodeficiency virus type 1 drug-resistant mutants by use of massively parallel sequencingSimple, sensitive, and specific detection of human immunodeficiency virus type 1 subtype B DNA in dried blood samples for diagnosis in infants in the fieldOligonucleotide ligation assay for detection of mutations associated with reverse transcriptase and protease inhibitor resistance in non-B subtypes and recombinant forms of human immunodeficiency virus type 1.Sensitive phenotypic detection of minor drug-resistant human immunodeficiency virus type 1 reverse transcriptase variants.Mutagenically separated PCR assay for rapid detection of M41L and K70R zidovudine resistance mutations in CRF01_AE (subtype E) human immunodeficiency virus type 1.Rapid and sensitive oligonucleotide ligation assay for detection of mutations in human immunodeficiency virus type 1 associated with high-level resistance to protease inhibitors.Herpes simplex virus type 2 suppressive therapy with acyclovir or valacyclovir does not select for specific HIV-1 resistance in HIV-1/HSV-2 dually infected persons.Nevirapine resistance by timing of HIV type 1 infection in infants treated with single-dose nevirapine.Blinded, multicenter comparison of methods to detect a drug-resistant mutant of human immunodeficiency virus type 1 at low frequency.Optimization of the oligonucleotide ligation assay for the detection of nevirapine resistance mutations in Zimbabwean Human Immunodeficiency Virus type-1 subtype CTransmitted HIV resistance to first-line antiretroviral therapy in Lima, Peru.Characterization of mutation spectra with ultra-deep pyrosequencing: application to HIV-1 drug resistanceSensitive oligonucleotide ligation assay for low-level detection of nevirapine resistance mutations in human immunodeficiency virus type 1 quasispeciesMonitoring of HIV type 1 DNA load and drug resistance in peripheral blood mononuclear cells during suppressive antiretroviral therapy does not predict virologic failure.Clinical implications of HIV-1 minority variantsStructured treatment interruptions (STIs) in HIV-1 infected pediatric populations increases interferon gamma production and reduces viremia.Application of a novel, rapid, and sensitive oligonucleotide ligation assay for detection of cancer-predicting mutations in the precore and basal core promoter of hepatitis B virus.Optimization of the oligonucleotide ligation assay, a rapid and inexpensive test for detection of HIV-1 drug resistance mutations, for non-North American variants.Simultaneous and sensitive detection of human immunodeficiency virus type 1 (HIV) drug resistant genotypes by multiplex oligonucleotide ligation assay.Novel enzyme-linked minisequence assay for genotypic analysis of human immunodeficiency virus type 1 drug resistance.Comparison of oligonucleotide ligation assay and consensus sequencing for detection of drug-resistant mutants of human immunodeficiency virus type 1 in peripheral blood mononuclear cells and plasma.Persistence of human immunodeficiency virus type 1 subtype B DNA in dried-blood samples on FTA filter paper.Multiple viral genetic analyses detect low-level human immunodeficiency virus type 1 replication during effective highly active antiretroviral therapy.Sequencing-based detection of low-frequency human immunodeficiency virus type 1 drug-resistant mutants by an RNA/DNA heteroduplex generator-tracking assayDevelopment and evaluation of an oligonucleotide ligation assay for detection of drug resistance-associated mutations in the human immunodeficiency virus type 2 pol gene.Paper-based detection of HIV-1 drug resistance using isothermal amplification and an oligonucleotide ligation assay.
P2860
Q28478459-D7DA692D-7650-42E8-8915-ACEA3F5C21FAQ28547874-CEDFB775-E8F5-48F6-A83B-D68A32964B91Q28552499-600BB8A5-C96B-4293-B2F4-5548F560056BQ33686931-D88A0F92-9E40-4B27-B7F9-BDE7AE429091Q33899918-C18A6620-4977-4A5D-8DCA-2A2061EED582Q33970771-DA63315E-E960-4C42-B018-7E6BCCE3ADF8Q34073276-FB12D749-600D-4CED-ABA2-584E95E788D4Q34143613-DD09F0CF-8923-4430-9944-A1DE56878C34Q34252835-C9496632-CD55-4E7F-8BD5-FC5E5BBE4A7BQ34454630-D0CC5D8D-2C1D-487B-9D67-4005E74732B6Q34508433-16F421BC-5E12-4131-93C4-B0EB408763C6Q34572571-CDA98C31-4E30-46A2-A828-339BE9D760CCQ34719734-9A77BE98-F2AC-4D00-A378-465462337C27Q35187157-37DE7902-20A8-4608-93A2-84D454C0F95FQ35862295-732F7881-8A5D-4634-99B8-97BC0F330856Q35914785-BDE20CB9-F57E-45EF-8648-5CC645625A98Q35947480-2A4C1CF3-FE4B-4A04-9651-03FD77A43408Q36102538-15FDEAE1-64FA-4BE6-A0E3-420EB3F754ECQ36811249-8CB23CEE-0D41-480F-90E7-9012DE084D53Q36814047-2107514C-9B0F-4221-905B-777F0AA6FE0AQ36845456-9E615B90-A587-4CDB-9E63-310BC1903E8FQ36973809-2BD10372-ECDC-4749-899D-3975437AF480Q37003038-DE4852D3-6F2C-4E74-883D-527AFFAC708FQ37058422-3DE41148-F0D3-4DD5-B15D-8EE55BEBE678Q37156918-BD20FAE4-FD9C-422B-9E83-E6466D31E020Q39487409-22E832E9-7C28-4FF7-9631-30063CDA700DQ39748924-6E8459D9-6A00-4FAD-A13B-88BAC224E062Q40909665-924572F3-5353-47E9-805F-BB07BEE05483Q41761525-6553E551-7AC1-4CC5-8398-B119F8274FF5Q47566956-D78B685F-CAA5-4ED3-BAF4-B333382EAC44
P2860
Oligonucleotide ligation assay for detecting mutations in the human immunodeficiency virus type 1 pol gene that are associated with resistance to zidovudine, didanosine, and lamivudine.
description
1998 nî lūn-bûn
@nan
1998 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Oligonucleotide ligation assay ...... e, didanosine, and lamivudine.
@ast
Oligonucleotide ligation assay ...... e, didanosine, and lamivudine.
@en
type
label
Oligonucleotide ligation assay ...... e, didanosine, and lamivudine.
@ast
Oligonucleotide ligation assay ...... e, didanosine, and lamivudine.
@en
prefLabel
Oligonucleotide ligation assay ...... e, didanosine, and lamivudine.
@ast
Oligonucleotide ligation assay ...... e, didanosine, and lamivudine.
@en
P2093
P2860
P1476
Oligonucleotide ligation assay ...... ne, didanosine, and lamivudine
@en
P2093
D A Nickerson
L A Manns-Arcuino
L M Frenkel
R E Edelstein
P2860
P304
P407
P577
1998-02-01T00:00:00Z